Medicover AB (MCVEF)
27.25
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Medicover Shareholders Equity (Quarterly) : 613.72M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 613.72M |
| March 31, 2026 | 630.60M |
| December 31, 2025 | 625.75M |
| September 30, 2025 | 596.55M |
| June 30, 2025 | 548.66M |
| March 31, 2025 | 526.81M |
| December 31, 2024 | 481.30M |
| September 30, 2024 | 556.91M |
| June 30, 2024 | 535.77M |
| March 31, 2024 | 548.86M |
| December 31, 2023 | 548.46M |
| September 30, 2023 | 492.42M |
| June 30, 2023 | 529.46M |
| March 31, 2023 | 518.89M |
| December 31, 2022 | 504.17M |
| September 30, 2022 | 461.61M |
| June 30, 2022 | 512.48M |
| March 31, 2022 | 567.56M |
| December 31, 2021 | 588.61M |
| September 30, 2021 | 567.77M |
| June 30, 2021 | 594.02M |
| Date | Value |
|---|---|
| March 31, 2021 | 557.80M |
| December 31, 2020 | 548.15M |
| September 30, 2020 | 518.43M |
| June 30, 2020 | 489.58M |
| March 31, 2020 | 327.64M |
| December 31, 2019 | 356.28M |
| September 30, 2019 | 355.41M |
| June 30, 2019 | 369.43M |
| March 31, 2019 | 356.06M |
| December 31, 2018 | 357.92M |
| September 30, 2018 | 358.79M |
| June 30, 2018 | 356.22M |
| March 31, 2018 | 370.43M |
| December 31, 2017 | 360.60M |
| September 30, 2017 | 354.78M |
| June 30, 2017 | 341.71M |
| March 31, 2017 | 106.10M |
| December 31, 2016 | 97.78M |
| September 30, 2016 | 99.68M |
| June 30, 2016 | 93.76M |
| March 31, 2016 | 102.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 7.516B |
| Labcorp Holdings, Inc. | 8.607B |
| OPKO Health, Inc. | 1.184B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 785.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.785B |
| Total Liabilities (Quarterly) | 2.152B |
| Debt to Equity Ratio | 2.723 |
| Current Ratio | 0.55 |
| Net Debt Paydown Yield | -1.80% |